Research Article
Amyloid-Beta 1-42 Cross-Reactive Antibody Prevalent in Human Sera May Contribute to Intraneuronal Deposition of A-Beta-P-42
Table 2
Percentage of elevation of autoantibodies in controls and AD patients at 2SD above the mean of controls.
| | Variables | Controls | AD Patients |
| | AßP-42 peptide | 4% | 22% | | Amyloid β protein | 8% | 37% | | Tau protein | 11% | 26% | | α-synuclein | 8% | 13% | | Presenilin | 13% | 17% | | Adenosine triphosphate synthase | 8% | 17% | | Rabaptin-5 | 6% | 6% | | S100B | 8% | 22% | | Aquaporin-4 | 8% | 22% | | Claudin-5 | 11% | 15% | | Glial fibrillary acidic protein | 8% | 28% | | Myelin basic protein | 6% | 20% | | Asialoganglioside GM1 | 8% | 15% | | β-nerve growth factor | 11% | 26% | | Brain-derived neurotrophic factor | 6% | 17% | | Glutamate receptor | 6% | 26% | | N-methyl-D-aspartate receptor | 8% | 26% | | Dopamine receptors 1, 2 | 11% | 28% | | Glutamic acid decarboxylase 65 | 8% | 22% | | Transglutaminase-2 | 6% | 24% | | Transglutaminase-3 | 8% | 31% | | Microbial transglutaminase | 6% | 24% | | Enteric nerve neuronal nuclear antigen | 6% | 24% |
|
|
